Connect with us

News

Half Of Hospitalised Covid Patients Have Persisting Symptoms After A Year: Lancet Study

The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with COVID-19

Half Of Hospitalised Covid Patients Have Persisting Symptoms After A Year: Lancet Study
Highlights
  • While most made a good recovery, health problems persisted in some: Study
  • Recovery for some patients will take longer than one year: Study
  • Patients reported experiencing shortness of breath at12 months: Study

Beijing: Around half the people hospitalised with COVID-19 experience at least one persistent symptom up to 12 months after the infection, according to a study published in The Lancet journal on Friday (August 27). The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with COVID-19.

Also Read: What Are COVID-19 Breakthrough Infections? How Long Does Immunity Last After COVID-19 Vaccination? An Expert Explains

COVID-19 survivors were found to be less healthy than people from the wider community who had not been infected with the SARS-CoV-2 virus, which causes COVID-19. “Our study is the largest to date to assess the health outcomes of hospitalised COVID-19 survivors after 12 months of becoming ill,” said Professor Bin Cao, from China-Japan Friendship Hospital.

While most had made a good recovery, health problems persisted in some patients, especially those who had been critically ill during their hospital stay, Professor Cao said.

The study findings suggest that recovery for some patients will take longer than one year, and this should be taken into account when planning delivery of healthcare services post-pandemic.

A previous study by the same team on 1,733 hospitalised COVID-19 survivors found that around three-quarters of patients had persistent health problems after six months of infection. The new study analysed data from patients who had been discharged from hospital between January 7 and May 29, 2020.

The patients underwent detailed health checks at six and 12 months to assess any ongoing symptoms and their health-related quality of life. These included face-to-face questionnaires, physical examinations, lab tests, and a six-minute walking test to gauge patients’ endurance levels.

Also Read: Mumbai Gets Ready For The Third Wave Of Coronavirus, Inaugurates COVID Care Center For Children

The average age of patients included in the study was 57 years. Patient outcomes were tracked for an average of 185 days and 349 days. Many symptoms resolved over time, regardless of the severity of initial COVID-19 disease, the researchers said. However, the proportion of patients still experiencing at least one symptom after one year fell from 68 per cent at six months to 49 per cent at 12 months, they said.

This decrease was observed regardless of the severity of COVID-19 the patients had experienced when hospitalised. The study shows that fatigue or muscle weakness was the most commonly reported symptom with around half of patients experiencing this at six months, falling to one in five patients at one year.

Almost one third of patients reported experiencing shortness of breath at 12 months, which was slightly higher than at six months, according to the researchers. This was more prevalent in patients who had been the most severely ill and had been on a ventilator during their time in hospital, compared to those who had not required oxygen treatment, they said.

At the six-month check, 349 study participants underwent a lung function test and 244 of those patients completed the same test at 12 months. The proportion of patients experiencing diffusion impairment did not improve from six months to 12 months and this was seen across all groups regardless of how ill they had been when hospitalised. Also at the six-month check, 353 study participants underwent a chest CT scan.

The researchers found that around one half of them showed lung abnormalities on their scan. Of the 118 patients who completed the scan at 12 months, the proportion of patients with abnormalities decreased substantially across all groups but was still high, particularly in the most critically ill group, they said. Compared with men, women were 1.4 times more likely to report fatigue or muscle weakness, twice as likely to report anxiety or depression, and almost three times as likely to have lung diffusion impairment after 12 months, according to the study.

People who had been treated with corticosteroids during the acute phase of their illness with COVID-19 were 1.5 times as likely to experience fatigue or muscle weakness after 12 months, compared to those who had not been treated during their illness. The researchers found that slightly more patients experienced anxiety or depression at one year than at six months and the proportion was much greater in COVID-19 survivors than in matched people from the wider community.

We do not yet fully understand why psychiatric symptoms are slightly more common at one year than at six months in COVID-19 survivors. These could be caused by a biological process linked to the virus infection itself, or the body’s immune response to it. Or they could be linked to reduced social contact, loneliness, incomplete recovery of physical health or loss of employment associated with illness, said Xiaoying Gu, one of the study’s authors, from China-Japan Friendship Hospital.

The authors acknowledged that their study was focused on a single hospital and so patient outcomes may not be generalisable to other settings. The study included only a small number of patients who had been admitted to intensive care and findings relating to the most critically ill patients should be interpreted with caution, they added.

Also Read: Experts On WHO Team Say Search For COVID Origins Has Stalled

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Click to comment

Leave a Reply

Your email address will not be published.

Folk Music For A Swasth India

RajasthanDay” src=

Reckitt’s Commitment To A Better Future

Expert Blog

हिंदी में पड़े

Latest Posts